1,522
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19

, ORCID Icon, , , , , , , , , & ORCID Icon show all
Pages 417-424 | Received 12 Nov 2020, Accepted 13 Mar 2021, Published online: 05 Apr 2021

References

  • Alhazzani, W., et al., 2020. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive care medicine, 46 (5), 854–887.
  • Andaluz-Ojeda, D., et al., 2017. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity. Annals of intensive care, 7 (1), 15.
  • Andrés, C., et al., 2020. MR-proADM to detect specific types of organ failure in infection. European journal of clinical investigation, 50 (6), e13246.
  • Baldirà, J., et al., 2020. Biomarkers and clinical scores to aid the identification of disease severity and intensive care requirement following activation of an in-hospital sepsis code. Annals of intensive care, 10 (1), 7.
  • Caruhel, P., et al., 2009. Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR. Clinical biochemistry, 42 (7–8), 725–728.
  • Charlson, M.E., et al., 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases, 40 (5), 373–383.
  • Chen, N., et al., 2020a. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395 (10223), 507–513.
  • Chen, Y.T., et al., 2020b. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Critical care, 24 (1), 346.
  • Cheng, Y., et al., 2020. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney international, 97 (5), 829–838.
  • Elke, G., et al., 2018. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis – a secondary analysis of a large randomised controlled trial. Critical Care, 22 (1), 79:
  • Gabarre, P., et al., 2020. Acute kidney injury in critically ill patients with COVID-19. Intensive care medicine, 46 (7), 1310–1339.
  • Gaudry, S., et al., 2016. Initiation strategies for renal-replacement therapy in the intensive care unit. New England journal of medicine, 375 (2), 122–133.
  • Grasselli, G., Pesenti, A., and Cecconi, M., 2020. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA, 323 (16), 1545–1546.
  • Gross, O., et al., 2020. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet, 395 (10236), e87–e88.
  • Guan, W.J., et al., 2020. Clinical characteristics of coronavirus disease 2019 in China. The new England journal of medicine, 382 (18), 1708–1720.
  • Hinson, J.P., Kapas, S., and Smith, D.M., 2000. Adrenomedullin, a multifunctional regulatory peptide. Endocrine reviews, 21 (2), 138–167.
  • Hirsch, J.S., et al., 2020. Acute kidney injury in patients hospitalized with COVID-19. Kidney international, 98 (1), 209–218.
  • Huang, C., et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395 (10223), 497–506.
  • Investigators, R.R.T.S., et al., 2009. Intensity of continuous renal-replacement therapy in critically ill patients. New England journal of medicine, 361 (17), 1627–1638.
  • Joannidis, M., and John, S., 2018. Acute kidney injury and renal replacement therapy in critically ill patients in 2018: recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI. Medizinische klinik - intensivmedizin und notfallmedizin, 113 (5), 356–357.
  • Kluge, S., et al., 2020. German recommendations for critically ill patients with COVID-19. Medizinische klinik, intensivmedizin und notfallmedizin, 115 (Suppl 3), 111–114.
  • Le Gall, J.R., Lemeshow, S., and Saulnier, F., 1993. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA, 270 (24), 2957–2963.
  • Lin, G.-L., et al., 2018. Epidemiology and immune pathogenesis of viral sepsis. Frontiers in immunology, 9, 2147–2147.
  • McNicholas, B.A., et al., 2019. Impact of early acute kidney injury on management and outcome in patients with acute respiratory distress syndrome: a secondary analysis of a multicenter observational study. Critical care medicine , 47 (9), 1216–1225.
  • Mearelli, F., et al., 2020. The integration of qSOFA with clinical variables and serum biomarkers improves the prognostic value of qSOFA alone in patients with suspected or confirmed sepsis at ED admission. Journal of clinical medicine, 9 (4), 1205.
  • Nierhaus, A., et al., 2018. Predicting the requirement for renal replacement therapy in intensive care patients with sepsis. Critical care, 22 (1), 201.
  • Önal, U., et al., 2018. Mid-regional pro-adrenomedullin (MR-proADM) as a biomarker for sepsis and septic shock: narrative review. Healthcare, 6 (3), 110.
  • Panitchote, A., et al., 2019. Factors associated with acute kidney injury in acute respiratory distress syndrome. Annals of intensive care, 9 (1), 74.
  • Pons, S., et al., 2020. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Critical care, 24 (1), 353.
  • Puelles, V.G., et al., 2020. Multiorgan and renal tropism of SARS-CoV-2. New England journal of medicine, 383 (6), 590–592.
  • Ranieri, V.M., et al., 2012. Acute respiratory distress syndrome: the Berlin Definition. JAMA, 307 (23), 2526–2533.
  • Richardson, S., et al., 2020. Consortium atNC-R: presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA, 323 (20), 2052–2059.
  • Roedl, K., et al., 2019. The chronic ICU patient: is intensive care worthwhile for patients with very prolonged ICU-stay (≥90 days)? European journal of internal medicine, 69, 71–76.
  • Ronco, C., Reis, T., and Husain-Syed, F., 2020. Management of acute kidney injury in patients with COVID-19. The lancet. Respiratory medicine, 8 (7), 738–742.
  • Ruan, Q., et al., 2020. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine, 46 (5), 846–848.
  • Spoto, S., et al., 2020. How biomarkers can improve pneumonia diagnosis and prognosis: procalcitonin and mid-regional-pro-adrenomedullin. Biomarkers in medicine, 14 (7), 549–562.
  • Teijaro, J.R., et al., 2011. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell, 146 (6), 980–991.
  • Vincent, J.L., et al., 1996. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive care medicine, 22 (7), 707–710.
  • Wang, C., et al., 2020. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Intensive care medicine, 46 (7), 1472–1475.
  • WHO – World Map – COVID-19. 2020. Accessed January, 15, 2020.
  • Yang, X., et al., 2020. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Critical care, 24 (1), 356.
  • Zarbock, A., et al., 2016. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA, 315 (20), 2190–2199.
  • Zarbock, A., Gomez, H., and Kellum, J.A., 2014. Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies. Current opinion in critical care, 20 (6), 588–595.
  • Zhou, F., et al., 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan. The lancet , 395 (10229), 1054–1062.
  • Ziesmann, M.T., and Marshall, J.C., 2018. Multiple organ dysfunction: the defining syndrome of sepsis. Surgical infections, 19 (2), 184–190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.